Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma

Fig. 3

Expression of marker proteins in MNOs. A IHC images using antibodies against CD31, CD68, Iba1, Vimentin, and PR in MNO21-03. B IHC images using antibodies against CD3, Olig2, SOX2, PanCK, and GFAP in MNO21-03. Lower panels show the enlarged area marked by black boxes in the upper panels. Scale bars indicate 200 μm (upper panels) and 20 μm (lower panels)

Back to article page